Attached files
| file | filename |
|---|---|
| EX-31.2 - CURATIVE BIOSCIENCES, INC. | ex31-2.htm |
| EX-31.1 - CURATIVE BIOSCIENCES, INC. | ex31-1.htm |
| 10-K - CURATIVE BIOSCIENCES, INC. | form10-k.htm |
Exhibit 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SS. 1350 ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Report of Curative Biosciences, Inc. (the “Company”), (formerly Amaize Beverage Corporation) on Form 10-K for the for the year ended June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Richard Damion, Chief Executive Officer and William Lindberg, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| /s/ Richard Damian | /s/ William Lindberg | |
| Richard Damian | William Lindberg | |
| Chief Executive Officer | Chief Financial Officer | |
| February 23, 2018 | February 23, 2018 |